'U-turn' over sight-saving drugs
A controversial decision to limit drugs for a major cause of blindness has been reversed by the NHS drug watchdog in England and Wales. The National Institute for Health and Clinical Excellence (NICE) reconsidered its guidance after 13,000 complaints.